Temporal mechanisms of myogenic specification in human induced pluripotent stem cells.
P NayakA ColasMark MercolaShyni VargheseShankar SubramaniamPublished in: Science advances (2021)
Understanding the mechanisms of myogenesis in human induced pluripotent stem cells (hiPSCs) is a prerequisite to achieving patient-specific therapy for diseases of skeletal muscle. hiPSCs of different origin show distinctive kinetics and ability to differentiate into myocytes. To address the unique cellular and temporal context of hiPSC differentiation, we perform a longitudinal comparison of the transcriptomic profiles of three hiPSC lines that display differential myogenic specification, one robust and two blunted. We detail temporal differences in mechanisms that lead to robust myogenic specification. We show gene expression signatures of putative cell subpopulations and extracellular matrix components that may support myogenesis. Furthermore, we show that targeted knockdown of ZIC3 at the outset of differentiation leads to improved myogenic specification in blunted hiPSC lines. Our study suggests that β-catenin transcriptional cofactors mediate cross-talk between multiple cellular processes and exogenous cues to facilitate specification of hiPSCs to mesoderm lineage, leading to robust myogenesis.
Keyphrases
- induced pluripotent stem cells
- skeletal muscle
- cell fate
- gene expression
- extracellular matrix
- single cell
- insulin resistance
- dna methylation
- endothelial cells
- epithelial mesenchymal transition
- cell proliferation
- genome wide
- transcription factor
- drug delivery
- stem cells
- cancer therapy
- pluripotent stem cells
- bone marrow
- adipose tissue
- heat shock protein